Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study.
about
Vasopressors for hypotensive shockVasopressors and predominantly vasoconstrictive drugs for acute myocardial infarction complicated by cardiogenic shockInotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndromeInotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndromePopulation pharmacokinetics and haemodynamic effects of norepinephrine in hypotensive critically ill children.The effectiveness of inodilators in reducing short term mortality among patient with severe cardiogenic shock: a propensity-based analysisCatecholamine and volume therapy for cardiac surgery in Germany--results from a postal survey.Safety and effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: a randomized double-blind, dose-dependent, phase IV clinical trialExperts' recommendations for the management of cardiogenic shock in childrenCurrent real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortalityProphylactic amiodarone and lidocaine improve survival in an ovine model of large size myocardial infarctionEtiology and therapeutic approach to elevated lactate levelsMechanisms underlying hemodynamic and neuroendocrine stress reactivity at different phases of the menstrual cycle.Hemodynamic management of cardiovascular failure by using PCO(2) venous-arterial difference.Pharmacotherapy update on the use of vasopressors and inotropes in the intensive care unit.Dobutamine Therapy is Associated with Worse Clinical Outcomes Compared with Nesiritide Therapy for Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis.Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance.Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy.Risk factors of post-operative severe hyperlactatemia and lactic acidosis following laparoscopic resection for pheochromocytoma.Hyperlactatemia and Cardiac Surgery.Improvement in perioperative care in pediatric cardiac surgery by shifting the primary focus of treatment from cardiac output to perfusion pressure: Are beta stimulants still needed?Singapore Paediatric Resuscitation Guidelines 2016.Experts' recommendations for the management of adult patients with cardiogenic shock.Outcomes of patients on multiple vasoactive drugs for shock.Metabolic effects of three different inotropic strategies in the newborn piglet myocardium.Dopamine versus norepinephrine in the treatment of cardiogenic shock: A PRISMA-compliant meta-analysis.Gastroprotective effect of palmatine against acetic acid-induced gastric ulcers in rats.Impact of the implementation of vasoactive drug protocols on safety and efficacy in the treatment of critically ill patients.Norepinephrine infusion improves haemodynamics in the preterm infants during septic shock.Vasopressors for acute myocardial infarction complicated by cardiogenic shock.[Cardiogenic shock : Current evidence].Pulmonary Hypertension in the Intensive Care Unit.Acute Heart Failure Management.Kurzdarstellung
P2860
Q24186138-6EB38FE3-B812-41CF-BC8B-37D274D711BBQ24187672-FCBFD917-0E57-4321-9CAE-9DC160805BECQ24201225-C25A2AAC-C40A-4E13-AC07-196BBCD0FFE9Q24203783-96E96F21-B09F-4DA0-99C3-CEDD1ADF7B1BQ34554480-4E2A3828-A3A8-4892-A443-C5DC263B1717Q34971810-81A79B08-EB00-4136-8198-F27AE76A1886Q35217267-580EA74D-DD42-4428-837A-6057EA897436Q35504933-7968D953-FC5F-4C28-AC7F-736DD1D7C101Q36581988-69725656-9F94-4D4E-B028-2F75B21ABA59Q37062075-9A6F6428-6B87-4947-B631-8D52EF0BF909Q37232553-410662EF-45EC-4F2A-8FCF-B85A2CB13CA3Q37685050-499AF7B9-8433-4A42-961B-327AD399305FQ37695510-8BD5C365-EDD4-4FCE-A218-0E3249964B25Q38029246-E875C10A-2D1B-4051-A84C-9BB669C1B6EDQ38272554-82280E9A-9F0B-43B5-9226-E6C4C8C13156Q38540286-066F5C75-B292-430F-A8B6-9C146473F3BAQ38561441-3D6AAD19-66DA-4D38-BF9F-7C16745E4776Q38875036-FFA3BD3B-8998-47D8-BBE8-0ADEA743431DQ38877264-DF151328-7615-4F8F-B1CB-C371BF37E63FQ39180776-551FEA0F-609E-41C3-B0B1-15C31CB2F5EFQ39190970-EAC21795-732E-4161-B816-AD3F38F3510DQ41098627-DE9A6C49-3441-4FB2-B357-43C86FB59C0CQ41256098-10A82289-57D4-49CF-8C8A-2F109AAD0002Q44463298-924525DD-287A-41D9-97FE-1B9685FC587BQ45101499-6CB92BED-B37B-453B-9540-4C40E4DCC370Q45718827-C52F9A50-35B4-4706-B773-B1101700CE4AQ47364412-3E3110C3-1283-4B65-901A-65E593F3465EQ47372535-63E17D24-1A90-4B76-B37A-E65D13C54202Q48220760-1CDE9113-339E-4E71-A069-FEE0B4A89454Q48543645-95853150-F328-4EFE-A994-F9CA8586F0A8Q49835894-7D8E229B-4407-4255-AA43-837502693B3CQ51633921-261D03B9-403B-44F4-BB42-FECA6F74E443Q55002696-71F8060A-4C69-457C-957E-C4106B78EB6FQ58037992-0F772C5C-559F-4E35-BEA7-C7B02B6EFB32
P2860
Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Comparison of norepinephrine-d ...... ctive, randomized pilot study.
@en
Comparison of norepinephrine-d ...... ctive, randomized pilot study.
@nl
type
label
Comparison of norepinephrine-d ...... ctive, randomized pilot study.
@en
Comparison of norepinephrine-d ...... ctive, randomized pilot study.
@nl
prefLabel
Comparison of norepinephrine-d ...... ctive, randomized pilot study.
@en
Comparison of norepinephrine-d ...... ctive, randomized pilot study.
@nl
P2093
P921
P1476
Comparison of norepinephrine-d ...... ctive, randomized pilot study.
@en
P2093
Alain Gerard
Bruno Levy
Carine Thivilier
Jessica Perny
Pierre Perez
P304
P356
10.1097/CCM.0B013E3181FFE0EB
P407
P577
2011-03-01T00:00:00Z